OSL:AZT • NO0010014632
The current stock price of AZT.OL is 24 NOK. In the past month the price increased by 10.09%. In the past year, price increased by 30.72%.
ChartMill assigns a technical rating of 6 / 10 to AZT.OL. When comparing the yearly performance of all stocks, AZT.OL turns out to be only a medium performer in the overall market: it outperformed 67.23% of all stocks.
ChartMill assigns a fundamental rating of 5 / 10 to AZT.OL. AZT.OL has an excellent financial health rating, but there are some minor concerns on its profitability.
Over the last trailing twelve months AZT.OL reported a non-GAAP Earnings per Share(EPS) of 0.19. The EPS increased by 35.71% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 7.43% | ||
| ROA | 2.17% | ||
| ROE | 2.32% | ||
| Debt/Equity | 0.01 |
6 analysts have analysed AZT.OL and the average price target is 33.66 NOK. This implies a price increase of 40.25% is expected in the next year compared to the current price of 24.
For the next year, analysts expect an EPS growth of 141.87% and a revenue growth 26.73% for AZT.OL
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| 1AE | ARGENX SE | 26.84 | 42.155B | ||
| ARGX | ARGENX SE | 25.91 | 40.348B | ||
| 22UA | BIONTECH SE-ADR | N/A | 22.218B | ||
| ABVX | ABIVAX SA | N/A | 8.129B | ||
| 2X1 | ABIVAX SA | N/A | 8.129B | ||
| GXE | GALAPAGOS NV | N/A | 1.914B | ||
| GLPG | GALAPAGOS NV | N/A | 1.866B | ||
| 6IV | INVENTIVA SA | N/A | 1.174B | ||
| IVA | INVENTIVA SA | N/A | 1.145B | ||
| NANO | NANOBIOTIX | N/A | 1.11B |
View all stocks in the Biotechnology Industry | View all stocks in the Health Care Sector | View all stocks on the Euronext Oslo Exchange | Find stocks with similar TA and Setup ratings on the European exchanges | Find stocks with similar Fundamental rating on the European exchanges | Find the competitors with the best technical ratings on the European exchanges | Find the competitors with the best fundamentals on the European exchanges | Find the competitors with the best valuation on the European exchanges | Find the competitors with the best dividend on the European exchanges | Find the competitors with the best analyst ratings on the European exchanges
ArcticZymes Technologies ASA is a holding company, which engages in the development, manufacture, and marketing of immunomodulatory products and cold adapted marine enzymes. As a life science company, Arcticzymes Technologies ASA is focused on the development, manufacturing, and commercialization of novel and high-quality recombinant enzymes for use in molecular research, In Vitro Diagnostics (IVD) and biomanufacturing. Some of the key features of the Company’s enzymes include cold activeness and salt tolerance. The Company’s divided into two operating segments; Enzymes and Corporate. Arcticzymes established logistic hubs in the United States and the Netherlands to serve its customers more efficiently.
ARCTICZYMES TECHNOLOGIES ASA
Sykehusveien 23
Tromso TROMS NO
Employees: 53
Phone: 4777648900
ArcticZymes Technologies ASA is a holding company, which engages in the development, manufacture, and marketing of immunomodulatory products and cold adapted marine enzymes. As a life science company, Arcticzymes Technologies ASA is focused on the development, manufacturing, and commercialization of novel and high-quality recombinant enzymes for use in molecular research, In Vitro Diagnostics (IVD) and biomanufacturing. Some of the key features of the Company’s enzymes include cold activeness and salt tolerance. The Company’s divided into two operating segments; Enzymes and Corporate. Arcticzymes established logistic hubs in the United States and the Netherlands to serve its customers more efficiently.
The current stock price of AZT.OL is 24 NOK. The price increased by 4.35% in the last trading session.
AZT.OL does not pay a dividend.
AZT.OL has a ChartMill Technical rating of 6 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
ARCTICZYMES TECHNOLOGIES ASA (AZT.OL) operates in the Health Care sector and the Biotechnology industry.
The PE ratio for ARCTICZYMES TECHNOLOGIES ASA (AZT.OL) is 126.32. This is based on the reported non-GAAP earnings per share of 0.19 and the current share price of 24 NOK.